OPKO's Farmadiet buy could swell Latin American sales
This article was originally published in Clinica
Executive Summary
The Miami-based biopharma and diagnostics company OPKO Health has acquired Barcelona, Spain-based Farmadiet Group Holding in a deal which brings it new products to sell through its existing channels in Latin America. OPKO also plans to use Farmadiet's European infrastructure to sell its diagnostic and pharmaceutical products in the EU.